FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
GlycoMimetics (NASDAQ: GLYC) reported Q1 EPS of ($0.33), $0.01 better than the analyst estimate of ($0.34).
The first quarter of 2019 was one of focused activity in the clinical development arena. We continued to identify and initiate new sites and enroll participants in our Company-sponsored Phase 3... More

